m 8218 has been researched along with Brain Ischemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, SL; Hu, B; Ma, TF; Ma, X; Qin, SJ; Wang, Y; Yan, JZ; Zhang, Y; Zhou, CH; Zhou, L | 1 |
Gu, PF; Li, Y; Shang, Y | 1 |
2 other study(ies) available for m 8218 and Brain Ischemia
Article | Year |
---|---|
A selective M1 and M3 receptor antagonist, penehyclidine hydrochloride, prevents postischemic LTP: involvement of NMDA receptors.
Topics: Animals; Brain Ischemia; Hippocampus; Long-Term Potentiation; Male; Neuroprotective Agents; Potassium Channel Blockers; Protein Kinase C; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Receptors, N-Methyl-D-Aspartate; Scopolamine; Small-Conductance Calcium-Activated Potassium Channels | 2013 |
[Penehyclidine hydrochloride inhibits glutamate release and related research in global brain ischemia/reperfusion rats].
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Cholinergic Antagonists; Glutamic Acid; Male; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2011 |